ÜSKÜDAR CANSU, D. Et Al. 2019. Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review. RHEUMATOLOGY INTERNATIONAL , vol.39, no.4 , 743-750.

ÜSKÜDAR CANSU, D., AKTAR DEMİRTAŞ, E., ANDIÇ, N., ÜSKÜDAR TEKE, H., & KORKMAZ, C., (2019). Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review. RHEUMATOLOGY INTERNATIONAL , vol.39, no.4, 743-750.

ÜSKÜDAR CANSU, DÖNDÜ Et Al. "Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review," RHEUMATOLOGY INTERNATIONAL , vol.39, no.4, 743-750, 2019

ÜSKÜDAR CANSU, DÖNDÜ Ü. Et Al. "Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review." RHEUMATOLOGY INTERNATIONAL , vol.39, no.4, pp.743-750, 2019

ÜSKÜDAR CANSU, D. Et Al. (2019) . "Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review." RHEUMATOLOGY INTERNATIONAL , vol.39, no.4, pp.743-750.

@article{article, author={DÖNDÜ ÜSKÜDAR CANSU Et Al. }, title={Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2019, pages={743-750} }